# A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted

> **NCT01443169** · PHASE1 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Sequence 1 - Treatment A: Controlled Release Pregabalin
- **DRUG:** Sequence 1 - Treatment B: Controlled Release Pregabalin
- **DRUG:** Sequence 1 - Treatment C:Controlled Release Pregabalin
- **DRUG:** Sequence 1 - Treatment D: Controlled Release Pregabalin
- **DRUG:** Sequence 1 - Treatment E: Immediate Release Pregabalin
- **DRUG:** Sequence 2 - Treatment B: Controlled Release Pregabalin
- **DRUG:** Sequence 2 - Treatment D: Controlled Release Pregabalin
- **DRUG:** Sequence 2 - Treatment A: Controlled Release Pregabalin
- **DRUG:** Sequence 2 - Treatment C: Controlled Release Pregabalin
- **DRUG:** Sequence 2 - Treatment E: Immediate Release Pregabalin
- **DRUG:** Sequence 3 - Treatment C: Controlled Release Pregabalin
- **DRUG:** Sequence 3 - Treatment A: Controlled Release Pregabalin
- **DRUG:** Sequence 3 - Treatment D: Controlled Release Pregabalin
- **DRUG:** Sequence 3 - Treatment B: Controlled Release Pregabalin
- **DRUG:** Sequence 3 - Treatment E: Immediate Release Pregabalin
- **DRUG:** Sequence 4 - Treatment D: Controlled Release Pregabalin
- **DRUG:** Sequence 4 - Treatment C: Controlled Release Pregabalin
- **DRUG:** Sequence 4 - Treatment B: Controlled Release Pregabalin
- **DRUG:** Sequence 4 - Treatment A: Controlled Release Pregabalin
- **DRUG:** Sequence 4 - Treatment E: Immediate Release Pregabalin

## Key facts

- **NCT ID:** NCT01443169
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01443169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01443169, "A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01443169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*